News

Only one group of stocks has come out on top in Donald Trump’s second term. The S&P 500 Consumer Staples sector is the only ...
President Donald Trump could be setting up Fed Chair Jerome Powell as a 'scapegoat' if a recession hits, according to an MSU ...
Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.
The Dow Jones fell on the stock market today. Treasury Secretary Bessent spoke on China. Bitcoin undercut $94,000 while Apple ...
A report Friday said sentiment among U.S. consumers sank in April, though not by as much as economists expected. The survey ...
The Dow Jones rose Monday as Nvidia stock declined on reports of a new AI chip out of China. Tesla stock rallied.
Pony AI shares jumped after the company said cost-cutting efforts are bringing it closer to profitability. The stock gained half its value Monday, hitting $10.54, and continuing a 132% run up over the ...
The stock and bond markets are awaiting news on trade deals as the Dow, S&P 500 and Nasdaq Composite look to build on last ...
Nearly a hundred days into his second term, the Hearst Television Data Team analyzed movements in inflation and the stock ...
Stock futures moved slightly lower Monday morning as investors get set for a flurry of earnings reports from major companies ...
The Magnificent Seven tech stocks, once the leaders of the stock market's bull run, are solidly in the red this year. The ...
Alnylam Pharmaceuticals said its RNAi therapeutic vutrisiran received a positive opinion recommending approval from the Committee for Medicinal Products for Human Use of the European Medicines Agency.